1.1An oxygen bridge
An ether oxygen joins two neighboring carbon atoms through single bonds. A separate tertiary amine takes up a proton in acidic water and supplies the positive charge.
Generated automatically. Not reviewed by a person. Not legal advice or an opinion.
Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
An ether oxygen joins two neighboring carbon atoms through single bonds. A separate tertiary amine takes up a proton in acidic water and supplies the positive charge.
The tail contains alternating silicon and oxygen atoms with methyl groups attached to silicon. The methyl-rich segment associates with other siloxane tails in water while the charged headgroups face the aqueous phase.
The groups on either side of B1 attach to opposite carbon atoms of a benzene ring. The rigid ring holds the two attachment points in opposing directions and limits bending across the spacer.
R1 contains a six-carbon chain with fluorine at every position that carries hydrogen in a hexyl group. In water, the fluorinated tails associate in a hydrophobic domain while the cationic headgroups contact the aqueous phase.
Six copies of the unit indexed by t1 connect in series between the adjacent groups. The added unit increases the length of the molecular path between those groups.
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
An aqueous dispersion of the carbon-core cationic lipid serves as a surface treatment for uncoated cellulose paper. A drawdown rod spreads the dispersion across the sheet, and protonated lipid headgroups adsorb to negatively charged sites on the fibers. A second coating pass applies a sulfonated dye, which associates with exposed cationic sites in the lipid layer.
The carbon-core cationic lipid serves as a collector in a bench flotation cell containing an aqueous silica slurry. A stirrer mixes the lipid dispersion into the slurry at a pH where the silica surface is negatively charged and the lipid headgroups are protonated. The headgroups adsorb to silica and expose hydrocarbon tails to the water. Air bubbles collect the conditioned particles and carry them into a froth that is skimmed from the cell.
Trans-1,4-cyclohexanediyl groups replace the acyclic alkylene spacers at B1 and B2. Each ring connects at carbon 1 to the core-facing side of its arm and at carbon 4 to the tail-facing side. The rings restrict spacer rotation while the hydrocarbon tails provide the hydrophobic portion of the molecule.
An ethanol solution of the carbon-core cationic lipid is deposited on 25 mm by 25 mm glass coupons. The deposited volumes give target dry loadings of 5, 25, and 100 micrograms per square centimeter after solvent evaporation. A contact-angle goniometer measures the angle of a 3 microliter water droplet 10 seconds after placement on each coating.
A thin silica layer covers the working electrode of a quartz crystal microbalance resonator in a liquid flow cell. An aqueous dispersion forms an adsorbed layer of the carbon-core cationic lipid on the silica, and a buffer rinse removes suspended material. The instrument records resonance frequency and dissipation as a sulfonated polymer solution flows over the layer, tracking changes in coupled mass and film mechanics.
A liquid handler dispenses the carbon-core cationic lipid dispersion into a plate containing buffers with different pH and salt concentrations. A robotic sampler transfers each mixture to an electrophoretic light-scattering cell, where the instrument measures electrophoretic mobility. Software associates each measurement with its buffer conditions and maps the mobility as a function of pH and salt concentration.
L2 uses a divalent ester linkage with the carbonyl carbon attached to one neighboring group and the single-bonded oxygen attached to the other. Hydrolysis splits the linkage into a carboxylic acid and an alcohol.
L5 is a single carbon–carbon bond between the terminal carbon atoms of the adjacent groups. The bond connects those groups without an intervening atom.
L3 uses a divalent ether oxygen, and L4 uses a divalent secondary amide group. Rotation about the ether bonds gives L3 conformational flexibility, while the amide bond holds the carbonyl carbon and nitrogen in a nearly planar arrangement.
A t3 value of one places one copy of the indexed unit between its neighboring groups. A t4 value of zero leaves its neighboring groups directly connected.
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
The benzophenone includes a substituent that has the linking group as the endgroup (i.e at the end of the substituent). A divalent linker joins the linking group to the benzophenone.A · US 2014/0272691 A1 · ¶ 86
In another embodiment, linkers are described having at least one hydrophobic side chain group, such as an alkyl, cycloalkyl, aryl, arylalkyl, or like group, each of which is optionally substituted.B · US 10,406,240 B2 · ¶ 61
wherein R and R′ are independently alkyl, aryl, alkenyl, halogen, sulfonate, phosphate, phosphonate, nitrile, thiophene, or pyrrole; p is an integer from 0 to 5; q is an integer from 0 to 4; and L is a single bond, oxyalkylene, alkyl, aryl, alkenyl, substituted alkyl, substituted aryl, substituted alkenyl, or amino; and Y is hydroxyl, alkoxy, aryloxy, or halogen; or an anhydride thereof.A · US 2014/0272691 A1 · ¶
wherein R is independently selected in each instance H, alkyl, heteroalkyl, cycloalkyl, heterocyclyl, alkenyl, alkynyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl, and the like, each of which is optionally substituted.B · US 10,406,240 B2 · ¶ 181
Exemplary divalent linkers include —CO—, —O—, —NH—, alkyl, aryl, and combinations thereof, and also include the single bond that can formed directly between the two different non-hydrogen atoms themselves.A · US 2014/0272691 A1 · ¶ 86
Generally, any manner of forming a conjugate between the bivalent linker (L) and the binding ligand (B), or analog or derivative thereof, between the bivalent linker (L) and the drug, or analog or derivative thereof, including any intervening heteroatoms, can be utilized in accordance with the present invention.B · US 10,406,240 B2 · ¶ 205
wherein R and R′ are independently alkyl, aryl, alkenyl, halogen, sulfonate, phosphate, phosphonate, nitrile, thiophene, or pyrrole; q and r are independently an integer from 0 to 4; and each L is independently a single bond, oxyalkylene, alkyl, aryl, alkenyl, substituted alkyl, substituted aryl, substituted alkenyl, or amino;A · US 2014/0272691 A1 · ¶
L is a divalent linker of 7 to 20 atoms in length, the divalent linker comprising a divalent alkylene group, a cycloalkylenecarbonyl group and a hydrophobic side chain divalent group comprising an arylalkyl side chain; and C is a chelating group of the formula wherein * is the point of attachment to the divalent linker; provided that the divalent linker has a single hydrophobic side chain divalent group in L.B · US 10,406,240 B2 · claim 1
wherein each R is independently alkyl, alkoxy, alkenyl, alkenyloxy, aryl, aryloxy, arylalkyl, or alkylaryl; and D is an average value of 2 to about 1000, specifically about 2 to about 500, more specifically about 10 to about 75; each M is independently cyano, nitro, alkyl, alkoxy, alkenyl, alkenyloxy, aryl, aryloxy, arylalkyl, or alkylaryl; each n is independently an integer from 0 to 4; and each R2 is independently an aliphatic group.A · US 2014/0272691 A1 · ¶
R2 represents a halogen atom, an alkyl group having 1 to 12 carbon atoms, an alkoxy group having 1 to 12 carbon atoms, an aryl group having 6 to 12 carbon atoms, an aryl-substituted alkenyl group having 7 to 13 carbon atoms, or a fluoroalkyl group having 1 to 12 carbon atoms; m represents an integer of 0 to 4; and n represents an integer of 0 to 14; wherein R1 to R4 are each independently a hydrogen atom, a hydrocarbon group with 1 to 9 carbon atoms which may contain an aromaA · US 2014/0272691 A1 · claim 7
wherein R is independently selected in each instance H, alkyl, heteroalkyl, cycloalkyl, heterocyclyl, alkenyl, alkynyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl, and the like, each of which is optionally substituted. It is to be understood that one R includes a heteroatom, such as nitro, oxygen, or sulfur, and is the point of attachment of linker L.B · US 10,406,240 B2 · ¶ 181
An empty cell means only that no passage was reproduced there.
However, they drip when exposed to a flame, and this dripping behavior worsens as the wall thickness decreases.A · US 2014/0272691 A1 · ¶ 4
The present disclosure relates to additives which can be used for crosslinking polycarbonate resins and improve their flame resistance.A · US 2014/0272691 A1 · ¶ 5
However, many of these treatments affect the quality of life of the patient, especially those men who are diagnosed with prostrate cancer over age 50.B · US 10,406,240 B2 · ¶ 3
The invention described herein pertains to compounds and methods for treating diseases of the prostate, such as prostate cancer and related diseases.B · US 10,406,240 B2 · ¶ 2
patent.fyi, US 2026/0356793 A1, claim 1, first published 2026-11-20T07:31:16-05:00, https://patent.fyi/US20260356793/, SHA-256 0848e87185ed1b24a6d70ab30e650511b38f726417019bc6cad1bc280a43a482